Source: Fox News
Summary
A new study published in the journal Cell explores the link between cancer history and reduced Alzheimer’s risk. Researchers used mouse models to investigate how biological changes associated with cancer may affect Alzheimer’s progression. The study found that certain cancers release a protein called cystatin-C, which can enter the brain and bind to harmful amyloid protein clumps linked to Alzheimer’s. This process activates immune cells that clear away existing amyloid plaques, reducing plaque buildup and improving cognitive function. The findings may help clarify a pattern observed by doctors for years, where people with a history of cancer are less likely to develop Alzheimer’s disease.
Our Reading
The advice sounds familiar.
This study reveals a complex relationship between cancer and Alzheimer’s, with certain cancers potentially triggering a protective mechanism in the brain. The protein cystatin-C, released by some cancers, may help clear away harmful amyloid plaques. This research suggests a new approach to Alzheimer’s treatments, targeting existing plaques rather than just early prevention. The study’s findings are notable, but further research is needed to determine if the same effects occur in humans. The puzzle of inverse comorbidity remains, where people with cancer are less likely to develop Alzheimer’s, and vice versa.
It’s a familiar pattern: a new study sheds light on a complex health issue, only to raise more questions and spark further research.
Author: Evan Null
